Black Bird Biotech, Inc.
BBBT
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 3.90K | 12.90K | 7.40K | 12.10K | 25.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.90K | 12.90K | 7.40K | 12.10K | 25.70K |
| Cost of Revenue | 2.50K | 5.90K | 8.30K | 32.80K | 12.40K |
| Gross Profit | 1.40K | 7.00K | -900.00 | -20.80K | 13.40K |
| SG&A Expenses | 11.20K | 100.40K | 80.70K | 104.60K | 169.40K |
| Depreciation & Amortization | 1.10K | 1.10K | 1.10K | 1.10K | 22.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.80K | 107.40K | 90.20K | 138.60K | 204.00K |
| Operating Income | -10.90K | -94.50K | -82.80K | -126.50K | -178.30K |
| Income Before Tax | -131.20K | -197.00K | -266.90K | -241.00K | -224.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -131.20K | -197.00K | -266.90K | -241.00K | -224.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -131.20K | -197.00K | -266.90K | -241.00K | -224.80K |
| EBIT | -10.90K | -94.50K | -82.80K | -126.50K | -178.30K |
| EBITDA | 41.60K | -18.20K | 76.00K | -125.40K | -156.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.46B | 635.30M | 433.17M | 419.22M | 293.00M |
| Average Diluted Shares Outstanding | 1.92B | 1.10B | 433.17M | 419.22M | 335.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |